About

Meet our team

Paratus is decoding evolution to discover and develop first-in-class medicines for serious diseases where today’s therapies fall short.

We are a global team of drug hunters dedicated to transforming nature’s most resilient traits into first-in-class medicines. Our interdisciplinary teams combine AI-powered discovery with deep drug development expertise to translate these insights into differentiated therapeutic programs.

Leadership

Alicia-Secor

Alicia Secor

President & Chief Executive Officer
Mark-Cockett

Mark Cockett, Ph.D.

Chief Scientific Officer
Jeff-Young

Jeffrey Young

Chief Financial Officer
Ganesh Mugundu

Ganesh Mugundu, M.Pharm, Ph.D.

Vice President, Head of Clinical Development
Richard-Polisson

Richard Polisson, M.D.

Senior Medical Advisor

Lewis Hong, Ph.D.

Vice President, Discovery Research and Site Head Singapore
Ranjit-Randhawa

Ranjit Randhawa, Ph.D.

Senior Vice President, Data Science and Computational Biology
Shian-Huey-Chiang

Shian-Huey Chiang, Ph.D.

Vice President, Discovery Research

Advisors

Paul Matsudaira, Ph.D.

Co-founder, Paratus

Emma Teeling, Ph.D.

Founding Advisor, Paratus
University College Dublin

Linfa Wang, Ph.D.

Founding Advisor, Paratus
Duke-NUS Medical School

Ruslan Medzhitov, Ph.D.

Yale University School of Medicine

Shiv Pillai, Ph.D., M.B.B.S.

Harvard Medical School

Investors

Join our mission

At Paratus, we are working to uncover new biology and translate it into medicines for patients who need better options. Explore opportunities to be part of a collaborative team advancing bold scientific ideas.

Scroll to Top